vs
Side-by-side financial comparison of DENNY'S Corp (DENN) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $113.2M, roughly 1.8× DENNY'S Corp). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 0.6%, a 56.8% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $16.0M).
Denny's is an American table service diner-style restaurant chain. It operates over 1,400 restaurants in the United States, Canada, México, Puerto Rico, and several other international locations.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
DENN vs IDYA — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $113.2M | $207.8M |
| Net Profit | $632.0K | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 9.2% | 52.2% |
| Net Margin | 0.6% | 57.4% |
| Revenue YoY | 1.3% | — |
| Net Profit YoY | -90.3% | 330.1% |
| EPS (diluted) | $0.01 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $113.2M | $207.8M | ||
| Q2 25 | $117.7M | — | ||
| Q1 25 | $111.6M | — | ||
| Q4 24 | $114.7M | — | ||
| Q3 24 | $111.8M | $0 | ||
| Q2 24 | $115.9M | $0 | ||
| Q1 24 | $110.0M | $0 | ||
| Q4 23 | $115.4M | — |
| Q3 25 | $632.0K | $119.2M | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $326.0K | — | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $6.5M | $-51.8M | ||
| Q2 24 | $3.6M | $-52.8M | ||
| Q1 24 | $4.7M | $-39.6M | ||
| Q4 23 | $2.9M | — |
| Q3 25 | 9.2% | 52.2% | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 9.1% | — | ||
| Q4 23 | 6.7% | — |
| Q3 25 | 0.6% | 57.4% | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 4.3% | — | ||
| Q4 23 | 2.5% | — |
| Q3 25 | $0.01 | $1.33 | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $0.13 | — | ||
| Q3 24 | $0.12 | $-0.60 | ||
| Q2 24 | $0.07 | $-0.68 | ||
| Q1 24 | $0.09 | $-0.53 | ||
| Q4 23 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-32.7M | $1.1B |
| Total Assets | $502.9M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $100.0K | — | ||
| Q3 24 | $2.9M | $920.0M | ||
| Q2 24 | $2.8M | $701.7M | ||
| Q1 24 | $2.8M | $698.8M | ||
| Q4 23 | $100.0K | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $270.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $264.6M | — |
| Q3 25 | $-32.7M | $1.1B | ||
| Q2 25 | $-34.6M | — | ||
| Q1 25 | $-36.4M | — | ||
| Q4 24 | $-34.0M | — | ||
| Q3 24 | $-54.5M | $1.2B | ||
| Q2 24 | $-53.2M | $931.7M | ||
| Q1 24 | $-55.7M | $935.3M | ||
| Q4 23 | $-62.7M | — |
| Q3 25 | $502.9M | $1.2B | ||
| Q2 25 | $491.1M | — | ||
| Q1 25 | $488.1M | — | ||
| Q4 24 | $496.3M | — | ||
| Q3 24 | $461.6M | $1.2B | ||
| Q2 24 | $459.9M | $973.7M | ||
| Q1 24 | $460.4M | $961.5M | ||
| Q4 23 | $464.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.0M | $142.2M |
| Free Cash FlowOCF − Capex | $16.0M | $142.2M |
| FCF MarginFCF / Revenue | 14.1% | 68.4% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 25.28× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $16.0M | $142.2M | ||
| Q2 25 | $9.4M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $6.6M | $-49.2M | ||
| Q2 24 | $14.2M | $-32.9M | ||
| Q1 24 | $215.0K | $-43.8M | ||
| Q4 23 | $21.4M | — |
| Q3 25 | $16.0M | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q4 23 | — | — |
| Q3 25 | 14.1% | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 25.28× | 1.19× | ||
| Q2 25 | 3.79× | — | ||
| Q1 25 | 15.38× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 3.97× | — | ||
| Q1 24 | 0.05× | — | ||
| Q4 23 | 7.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
IDYA
Segment breakdown not available.
